生物医药控股 BHVN 深 沪
等待开盘 02-07 09:30:00 美东时间
11.625
+0.875
+8.14%
华盛通- 最 高14.0069
- 今 开11.355
- 成交量 157.29万股
- 最 低 9.32
- 昨 收 10.75
- 总市值 82.59万
- 52周最高 14.0069
- 市盈率 静 --
- 换手率 2213.98%
- 52周最低 0.00
- 委 比 44.43%
- 总股本 7.10万
- 历史最高 14.0069
- 量 比 0.76
- 振 幅 43.60%
- 历史最低 0.00
- 每 手 1
- 风险率 7.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多US Stocks Mixed; Biohaven Shares Fall
U.S. stocks traded mixed this morning, with the Dow Jones index falling around ...
2025-12-26 22:45
Biohaven Misses The Mark In Depression Trial, Stock Falls
Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison to placebo.
2025-12-26 21:20
Nvidia, Sobr Safe And 3 Stocks To Watch Heading Into Friday
US stock futures slightly lower. Stocks to watch: NVIDIA, Dynavax, Sobr Safe, Davis Commodities, Biohaven.
2025-12-26 16:19
What Caused Biohaven (BHVN) Shares To Drop More Than 16% After Hours?
Biohaven shares fell 16.19% in after-hours trading Wednesday after its Phase 2 depression drug trial missed the primary endpoint.
2025-12-25 14:52
Biohaven Announces $150M Common Stock Offering
Biohaven Ltd. (NYSE:BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases,
2025-11-12 05:06
Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection
Biohaven stock plunged after the FDA rejected Vyglxia for spinocerebellar ataxia, prompting major R&D cuts and a William Blair downgrade.
2025-11-06 01:53
Crude Oil Down 1%; Solid Power Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
2025-11-06 01:05
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining mor...
2025-11-03 21:14
Biohaven盘中异动 下午盘急速下挫5.18%
北京时间2024年12月14日03时44分，Biohaven Ltd.（BHVN.us）股票出现波动，股价大幅跳水5.18%。截至发稿，该股报38.08美元/股，成交量53.4139万股，换手率0.53%，振幅5.80%。 最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.60亿美元，每股收益-1.70美元，毛利-1000000.00美元，市盈率-4.06倍。 机构评级方面，在所有15家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。 Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Innate Pharma、60 D...
2024-12-14 03:44
